GSK is one of the world’s leading vaccine companies, involved in vaccine research, development and production. We have 15 vaccines in development and our broad portfolio of 39 vaccines prevent illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, we have more than 16,000 people working to deliver nearly 2 (1.9) million vaccines every day, to people in around 90% (172) of the world’s countries. In 2015 we distributed around 690 million doses of vaccine, over 70% of them to least developed, low and middle income countries.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.